PP083—Dabigatran– demonstrates the need for comprehensive approaches to optimise the use of new drugs
Autor: | Malmstrom, R.E., Godman, B., Diogene, E., Bennie, M., Furst, J., Gutiérrez-Ibarluzea, I., McCullagh, L., Vlahovic-Palcevski, V., Gustafsson, L.L. |
---|---|
Zdroj: | In Clinical Therapeutics August 2013 35(8) Supplement:e43-e44 |
Databáze: | ScienceDirect |
Externí odkaz: |